Skip to main content
Have a personal or library account? Click to login
Comparison of SARS-CoV-2 vaccine induced antibody response among healthy individuals and chronic renal failure patients Cover

Comparison of SARS-CoV-2 vaccine induced antibody response among healthy individuals and chronic renal failure patients

Open Access
|Mar 2022

Abstract

AZD1222 (Covishield) COVID-19 vaccination response among healthy adults and chronic renal disease patients has been compared in this analysis. Compared to healthy individuals, vaccine induced immune response seems to be suboptimal after two doses of the vaccine in patients with chronic renal disease on hemodialysis. Infection following full course of vaccination can boost the vaccine induced antibody levels in both healthy individuals and patients with chronic renal disease.

It is necessary to conduct comprehensive prospective research to further evaluate these conclusions made based on this preliminary data evaluation, and to find out its overall impact for future SARS-CoV-2 infection and its disease outcome.

Language: English
Published on: Mar 21, 2022
Published by: Sri Lankan Society for Microbiology
In partnership with: Paradigm Publishing Services

© 2022 S. N. Janage, R. S. Sundararaj, L. S. Athukorala, K. D. S. T. Abeywardana, Y. Y. Udawatta, W. R. Dharmasiri, N. D. S. Arachchige, published by Sri Lankan Society for Microbiology
This work is licensed under the Creative Commons Attribution 4.0 License.